Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-15-060935
Filing Date
2015-10-27
Accepted
2015-10-27 12:13:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 v422744_424b3.htm 424B3 989584
2 GRAPHIC tlogo.jpg GRAPHIC 4436
3 GRAPHIC tpg4.jpg GRAPHIC 6227
  Complete submission text file 0001144204-15-060935.txt   1005554
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-204434 | Film No.: 151176779
SIC: 2834 Pharmaceutical Preparations